A number of West African countries are considering, or are already in the process of, revisiting their drug laws. The purpose of this Model Drug Law is to respond to this need for reform, by providing legislative provisions and commentary based on international and regional commitments.
In this response, IDPC analyses the 2017 INCB Annual Report, paying special attention to its foreword, its thematic chapter on treatment, as well as the cross-cutting issues of health, human rights and cannabis policies.
The 3rd Brandenburg Forum report outlines the discussions held by 56 experts from 15 countries on the state and direction of the global drug control regime in view of the 2019 CND Ministerial Segment.
The authors underscore the proven efficacy of these harm reduction interventions, underscoring the importance of further research into their different modalities of implementation.
The study discusses the experiences of peers who have utilised naloxone and provides avenues to incorporate these valuable insights into training materials and programme delivery.
The Pompidou Group provides a series of recommendations to ensure access to opioid agonist treatment, including amending prescription practices and reconsidering stigmatising terminology.
The Red Cross and Red Crescent Partnership on Substance Abuse recommends deploying overdose prevention strategies that empower communities and significantly expand access to naloxone.
UNAIDS sheds light on the global progress toward ending the AIDS epidemic, noting it has slipped dramatically off-track. People who inject drugs remain 22 times more likely to live with HIV than the general population.
The authors argue that despite the growing salience of harm reduction in the new Master Plan, implementation is likely to be significantly hindered by the 'war on drugs' framework that structures the country's drug control responses.
